The aim of the study was to evaluate the possibility of predicting potential epitope sequences and location in allergenic proteins from food using EVALLER program by comparison with experimental epitopes summarised in the BIOPEP database of allergenic proteins. Sequences of experimental epitopes from food allergens, present in the BIOPEP database of allergenic proteins were used in the study. Sequences of potential epitopes were found using EVALLER program. The Positive Predictive Value (PPV) has been used as a measure of prediction quality. The potential epitopes fully or partially overlapping with the experimental ones were considered as true positive results whereas these unrelated to the experimental ones as false positive results. The PPV for entire dataset containing 310 potential epitopes was 80.6%. The PPV varied signifi cantly among particular allergen families defi ned according to the AllFam database. Caseins revealed PPV=100% (with one exception), proteins from tropomyosin family and proteins from papain-like cystein protease family -exceeding 50%. The last two families possess also relatively low frequency of epitope occurrence. The predictive potential was poor (less than 50%) for plant allergens from cupin superfamily. Families such as lipocalins from milk and EF-hand family (parvalbumins) revealed high variability within family. The EVALLER program may be used as a tool for the prediction of epitope location although its potential varies considerably among allergen families. High PPV is associated with a high number of known experimental epitopes (such as in caseins) and/or a high degree of sequence conservation within family (caseins, tropomyosins).
INTRODUCTION
Allergy is one of the greatest challenges for the contemporary food science and medicine [Skripak & Sampson, 2008; Jędrychowski et al., 2008; Cianferoni & Spergel, 2009; Cummings et al., 2010] . Allergy treatment involves the elimination of allergens from the diet or desensitization therapy [Skripak & Sampson, 2008; Kim & Sicherer, 2010; Prescott et al., 2010] . For elimination diets and desensitization treatment to be effective, allergenic food proteins and protein fragments that are epitopes have to be determined. The relevant research is supported by bioinformatics tools [Tong & Ren, 2009; Mari et al., 2009; Salimi et al.; 2010; Tomar & De, 2010] . The bioinformatics tools applied in immunology and allergology include databases containing allergenic protein sequences [Gendel, 2009; Mari et al., 2009; Salimi et al., 2010; Tomar & De, 2010; Darewicz et al., 2011] . Those databases are compatible with applications comparing a given protein sequence with the sequences listed in the database. Most of such applications rely on BLAST [Altschul et al., 1997] and FASTA [Pearson et al., 1991; Pearson, 2000] algorithms. The existing databases support the evaluation of a protein's potential allergenicity based on a set of bioinformatics criteria recommended by the World * Corresponding author: Tel.: +4889 523 37 15 E-mail: jerzy.dziuba@uwm.edu.pl (Prof. J. Dziuba) Health Organization (WHO), such as the presence of protein sequence fragments containing a minimum of 6-8 amino acid residues which are identical to the fragments of known allergens or fragments containing a minimum of 80 amino acid residues showing at least 35% similarity with the known allergen sequence [Goodman, 2006] . The search for new solutions is still necessary to further advancement of the existing bioinformatics methods and tools [Gowthaman & Agrewala, 2009] . The list of applications that predict the allergenicity of proteins includes EVALLER program for predicting the allergenicity and cross-reactions of proteins [Martinez-- Barrio et al., 2007] . It compares protein sequence fragments with a database of fi ltered length-adjusted allergen peptides (FLAPs) [Soeria-Atmadja et al., 2006] , an improved version of the database of allergen-representative peptides developed by Björklund and coworkers [2005] . The above program searches for fragments in allergenic proteins, and it accounts for differences between those fragments and the sequences of non-allergenic proteins. The overlapping segments, selected based on the above criteria, were combined to form longer fragments -FLAPs. The EVALLER database comprises sequences of 762 allergenic proteins and twice more non-allergenic proteins. EVALLER relies on two criteria for evaluating the degree of sequence matching: the degree of identity expressed by the percentage of identical residues with the same position in a protein chain fragment, which accounts for insertion and deletion computed using the FASTA algorithm [Pearson, 1991; 2000] , and the Smith-Waterman score [Smith & Waterman, 1981] . The algorithm applied to develop the EVALLER program was compared with other algorithms investigating the allergenic character of the examined proteins [Soeria-Atmadja et al., 2006] . In reference to the offi cial bioinformatics criteria recommended by the WHO [Goodman, 2006] , the discussed program produces fewer false-positive results, i.e. cases in which a non-allergenic protein is found to be an allergen [Soeria-Atmadja et al., 2006] . According to a suggestion presented by Björklund et al. [2005] , peptides characteristic for allergens could overlap with experimental epitopes determined by mapping, i.e. based on interactions between the peptides corresponding to fragments of protein sequences and the antibodies of persons allergic to the analysed protein [Bohle, 2006; Steckelbroeck et al., 2008] . Comparison of the epitope determination using experimental mapping and prediction using EVALLER is presented in Figure 1 .
The aim of the present study was to evaluate the possibility of predicting potential epitope sequences and location in allergenic proteins from food using EVALLER program by comparison with experimental epitopes summarised in the BIOPEP database of allergenic proteins.
METHODS
Information about bioinformatics tools mentioned in this article, including web addresses and references (if available) is summarised in Table 1 . All databases and programs were accessed before 30.04.2011.
Sequences of food allergens and experimental epitopes present in the BIOPEP database of allergenic proteins were used in the study.
The BIOPEP database of allergenic proteins and their epitopes contains the following information: allergen name; sequence, sequences of experimental epitopes; sequences of predicted epitopes; reference describing proteins sequence (bookmark "reference"); reference concerning allergenicity, information about sequences of experimental and theoretical epitopes; ID of particular experimental epitopes in the Immune Epitope Database (bookmark "additional information"); information about AllFam allergen family and epitopes occurring in more than one protein in the BIOPEP database (bookmark "homology") and information about annotation in general protein database (mainly UniProt), WHO-IUIS (World Health Organization -International Union of Immunological Societies) and Allergome or other allergen databases (bookmark "database reference"). The BIOPEP database of allergenic protein and their epitopes contains also a search engine that enables fi nding fragments identical with epitopes in protein sequences (e.g. provided by user).
Sequences of potential epitopes were found using EVAL-LER program with default parameters. Number of sequences displayed in an output covered all sequences revealing 100% identity with fragments of known allergens (as recommended by Minkiewicz et al. [2011] ). All such fragments are annotated in the BIOPEP database. Sequences with a lower degree of identity were not taken into account. The frequency of occurrence of sequential epitopes (A) has been calculated automatically during introduction of protein data into the BIOPEP database according to equation 1 [Dziuba et al., 2003 ]. Both experimental and potential epitopes are included during calculation.
where: n -number of epitopes, and N-number of amino acid residues. Postive predictive value (PPV) has been used as a parameter estimating the quality of prediction of a potential epitope. The PPV may be considered as likelihood that potential epitope will fully or partially overlap with at least one experimental epitope. The PPV value has been calculated using equation 2 [Pulido et al., 2003] .
where: tp -true positive results, and fp -false positive values. Defi nitions of true and false positive values are presented in Figure 1 .
The total PPV value has been calculated for all proteins containing both potential and experimental epitopes. The PPV value for an individual allergen has been calculated only if the allergenic protein contains more than one potential epitope.
RESULTS AND DISCUSSION
Sixty proteins out of the 135 ones present in the BIOPEP database contain both potential and theoretical epitopes, and 43 of them contain at least two potential epitopes determined by EVALLER program. The data cover 310 allergen--representative FLAPs, of which 187 (60.3%) completely overlapped with the experimental epitopes, 63 (20.3%) partially overlapped with the experimental epitopes, and 60 (19.4%) were unrelated to the experimental epitopes. In line with the adopted sequence coverage criterion, a single FLAP has to be found in a single experimental epitope or a single experimental epitope has to be determined in a single FLAP to be considered as fully overlapping. Such a rule will be maintained in the further discussion. The Positive Predictive Value calculated for the entire dataset (total PPV) is 80.6%.
A group of experimental epitopes forming a continuous protein sequence fragment could overlap with a theoreticallypredicted allergenic peptide or a group of theoretically-predicted peptides (FLAPs) forming a continuous protein sequence fragment could overlap with an experimental epitope. An example of the above is an experimental epitope sequence containing residues 131-151 in the precursor of allergen Ara h 3.0101 (BIOPEP ID 47) which overlaps with a group of potential epitopes containing residues 108-135; 124-145; 126-147; 139-163; 144-165 and 149-184, respectively. None of the above FLAPs contains or is a part of an experimental epitope. Based on the above, the discussed FLAPs have been classifi ed as partially overlapping with experimental epitope. All six FLAPs create a continuous fragment of a protein sequence containing 100% experimental epitope amino acid residues. If similar epitope groups were to be classifi ed as completely overlapping, the number of completely overlapping sub-sets would increase to 192 (63.4% of all theoretically-predicted allergenic peptides), and the number of FLAPS that partially overlap with experimental epitopes would be reduced to 51 (16.8% of all theoretically-predicted allergenic peptides). The percentage of unrelated potential epitopes would be thus 19.8%.
Proteins containing at least 2 potential epitopes have been divided into subgroups according to A and PPV value as shown in Table 2 . For 27 out of 43 proteins mentioned in this table PPV=100%. It means that all potential epitopes found using EVALLER program in the sequences of proteins mentioned above, fully or partially cover known experimental epitopes. Proteins with A value lower than 0.2 are characterised by PPV from 0 to 100%. The PPV value of proteins possessing A values between 0.2 and 0.6 is between 50 and 100%. All proteins with the frequency of occurrence of sequential epitopes larger than 0.6 are characterised by a positive predictive value of 100%. It means that such proteins do not contain potential Table 3 . The discussed group includes the highest-risk allergens [Jędrychowski et al., 2008] . Milk proteins form a dominant group among the allergens characterised by high values of A indicating a high number of known experimental epitopes. They were subjected to extensive studies aimed at epitope determination as compared with allergenic proteins from other sources [Vaughan et al., 2010] . Moreover sequences of milk proteins are highly conserved and contain common experimental epitopes as pointed out by Minkiewicz et al. [Ishikawa et al., 1998a; b; , not mentioned in the IEDB-AR database, are also present in this allergen as well as in its homologs.
Ranges of A and PPV values of allergenic proteins belonging to different families are presented in Table 4 . Classifi cation (β-lactoglobulins) strongly depends on A value. It indicates that for some proteins belonging to this family knowledge concerning experimental epitopes may be incomplete. Bovine β-lactoglobulin (BIOPEP ID 14) was extensively studied to fi nd fragments interacting with the immunological system. Other proteins from this family contain epitopes identical with these from bovine protein. Lipocalins with a low number of such epitopes are also characterised by a low PPV value. Prediction of epitope location using EVALLER program appears to be promising for proteins revealing low A value and high PPV value, such as proteins from tropomyosin family and papain-like cystein protease family. The group with (Table 4) . Among proteins with a low number of known sequential epitopes prediction quality is rather poor for cupin superfamily. This family does not contain proteins with PPV=100%. Four of the six proteins from this family reveal PPV below 50%. The last family is EF--hand family (fi sh and amphibian parvalbumins). Among these proteins one has revealed PPV=100%, but two -PPV=0. Parvalbumins are characterised by high sequence variability. Their predicted secondary structure may also vary between species as shown on the example of proteins from Cyprinus carpio and Salmo salar [Iwaniak & Dziuba, 2011] . It is diffi cult to take any conclusions about predictability of epitope occurrence in proteins form the EF-hand family.
Allergens from the BIOPEP database, containing potential epitopes found by EVALLER program but not containing known experimental sequential epitopes are summarised in Table 5 . There is also no data concerning discontinuous epitopes or data concerning these allergens in IEDB or IEDB-3D [Ponomarenko et al., 2011 ], although we cannot exclude fi nding such epitopes in the future. Most of allergens indicated in Table 5 are of plant origin (cereals or leguminous plants). Some of allergen AllFam families indicated in Table 5 are represented also among the ones containing both potential and experimental epitopes (Table 4) . Proteins from the serum albumin, prolamine or Bet v 1-related family were characterised by a high positive predictive value with a relatively low frequency of epitope occurrence. Results concerning these families look promising in contrast with the proteins belonging to the Cupin and EF-hand families. On the other hand, we cannot exclude that these families contain proteins characterised by poor predictive values such as members of the EF-hand family with PPV=0. The BIOPEP database does not contain proteins from the Profi lin, Transferrin and Expansin C-terminal Domain families containing both experimental and potential epitopes.
A comparison with the experimental results is the only way to evaluate in silico prediction. Fragments typical of allergenic proteins, generated by program EVALLER reveal usually good (ca. 80%) likelihood of coverage with experimental epitopes. The suggestion that they cover such epitopes [Björklund et al., 2005] is thus generally confi rmed for the used dataset of food allergenic proteins and their epitopes. The positive predictive value may, however, vary among allergen families. The possibility of continuous update is a characteristic property of bioinformatic tools and is considered as major advantage [Wren & Bateman, 2008] . Further enrichment of both databases: BIOPEP and database used by EVALLER program, may lead to the improvement of the Positive Predictive Value concerning overlapping between potential and experimental epitopes.
CONCLUSIONS
Program EVALLER generates fragments characteristic for allergenic proteins (so called Filtered Length-Adjusted Allergenic Peptides -FLAPs). Most of such peptides present in the BIOPEP database of allergenic proteins (ca. 80 %) fully or partially overlap with the known experimental ones. Program EVALLER may thus be used as a tool for predicting epitope location although its potential varies considerably among allergen families. The predictive potential was good for milk proteins (α/β-caseins family and κ-caseins family), although these proteins possess numerous experimental epitopes. The predictive potential appears good also for invertebrate tropomyosins (tropomyosins family) and poor for plant allergens from the Cupin superfamily.
